Glyphic Biotechnologies
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
Work at Glyphic Biotechnologies in HR or recruiting? Claim this page
Headcount trend
Glyphic Biotechnologies went from 17 employees in Mar 2023 to 20 in Feb 2025. Sep 2024 to Feb 2025: 3 people joined, 1 left.
Headcount data through Feb 2025
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Feb 2024 | Venture | $33.2M | 2 | |
| Jul 2021 | Seed | $6M | 7 |
Org structure
Headcount by department
H-1B sponsorship
Peer reviews
Worked with someone at Glyphic Biotechnologies?
Anonymous peer reviews on OffTheRecord
Similar companies
Glyphic Biotechnologies FAQ
How many employees does Glyphic Biotechnologies have?
Glyphic Biotechnologies has about 20 employees, up 11.1% over the 3 months to Feb 2025.
Does Glyphic Biotechnologies sponsor H1B visas?
Yes. Glyphic Biotechnologies filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
How much funding has Glyphic Biotechnologies raised?
Glyphic Biotechnologies has raised $39.2M in total funding.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.